193
Views
50
CrossRef citations to date
0
Altmetric
Review

Troponin as a marker of myocardiac damage in drug-induced cardiotoxicity

, , , , , & show all
Pages 457-472 | Published online: 10 May 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Laila M. Sherief, Ahmad G. Kamal, E. A. Khalek, Naglaa M. Kamal, Attia A. A. Soliman & Asmaa M. Esh. (2012) Biomarkers and early detection of late onset anthracycline-induced cardiotoxicity in children. Hematology 17:3, pages 151-156.
Read now
Ashima Mathur & Y.K. Agrawal. (2011) An overview of methods used for estimation of time since death. Australian Journal of Forensic Sciences 43:4, pages 275-285.
Read now
Laura K. Schnackenberg & Richard D. Beger. (2008) The Role of Metabolic Biomarkers in Drug Toxicity Studies. Toxicology Mechanisms and Methods 18:4, pages 301-311.
Read now
Peter James O’Brien. (2006) Blood cardiac troponin in toxic myocardial injury: archetype of a translational safety biomarker. Expert Review of Molecular Diagnostics 6:5, pages 685-702.
Read now

Articles from other publishers (46)

Azibe Yıldız, Nigar Vardı, Hakan Parlakpınar, Burhan Ateş & Neriman Çolakoğlu. (2022) Effects of Low- and High-Dose Valproic Acid and Lamotrigine on the Heart in Female Rats. Cardiovascular Toxicology 22:4, pages 326-340.
Crossref
John O. Olanlokun, Wisdom Oshireku Abiodun, Oluwakemi Ebenezer, Neil A. Koorbanally & Olufunso Olabode Olorunsogo. (2022) Curcumin modulates multiple cell death, matrix metalloproteinase activation and cardiac protein release in susceptible and resistant Plasmodium berghei-infected mice. Biomedicine & Pharmacotherapy 146, pages 112454.
Crossref
Swaraj Mohanty & Yasmin Ahmad. 2022. Cardiovascular toxicity and therapeutic modalities targeting cardio-oncology. Cardiovascular toxicity and therapeutic modalities targeting cardio-oncology 65 82 .
V. De Sanctis, M. Alfò, C. Vitiello, G. Vullo, G. Facondo, L. Marinelli, S. Burocchi, G. Gallo, M. Valeriani, B. Campanella, G. Scalabrino, I. Russo, G. Salerno, P. Cardelli, M.F. Osti & L. De Biase. (2021) Markers of Cardiotoxicity in Early Breast Cancer Patients Treated With a Hypofractionated Schedule: A Prospective Study. Clinical Breast Cancer 21:3, pages e141-e149.
Crossref
Caelan Taggart, Ryan Wereski, Nicholas L. Mills & Andrew R. Chapman. (2021) Diagnosis, Investigation and Management of Patients with Acute and Chronic Myocardial Injury. Journal of Clinical Medicine 10:11, pages 2331.
Crossref
K. Pavithra, V. V. Sathibabu Uddandrao, P. Chandrasekaran, P. Brahmanaidu, S. Sengottuvelu, S. Vadivukkarasi & G. Saravanan. (2020) Phenolic fraction extracted from Kedrostis foetidissima leaves ameliorated isoproterenol‐induced cardiotoxicity in rats through restoration of cardiac antioxidant status . Journal of Food Biochemistry 44:11.
Crossref
Doudou Yan, Hui Wei, Xinning Lai, Yangyang Ge, Shilin Xu, Jie Meng, Tao Wen, Jian Liu, Weiqi Zhang, Jianxiang Wang & Haiyan Xu. (2020) Co-delivery of homoharringtonine and doxorubicin boosts therapeutic efficacy of refractory acute myeloid leukemia. Journal of Controlled Release 327, pages 766-778.
Crossref
Sangeethadevi Govindasami, Veera Venkata Sathibabu Uddandrao, Nivedha Raveendran & Vadivukkarasi Sasikumar. (2020) Therapeutic Potential of Biochanin-A Against Isoproterenol-Induced Myocardial Infarction in Rats. Cardiovascular & Hematological Agents in Medicinal Chemistry 18:1, pages 31-36.
Crossref
Manar Hamed Arafa, Nanies Sameeh Mohammad & Hebatallah Husseini Atteia. (2020) Rho-Kinase inhibitors ameliorate diclofenac-induced cardiotoxicity in chloroquine-treated adjuvant arthritic rats. Life Sciences 254, pages 117605.
Crossref
Ya SunGuangzhao QiDuolu LiHaiyang MengZhenfeng ZhuYongmei ZhaoYuedong QiXiaojian Zhang. (2019) Walnut ( Juglans regia L. ) Kernel Extracts Protect Against Isoproterenol-Induced Myocardial Infarction in Rats . Rejuvenation Research 22:4, pages 306-312.
Crossref
Williams E. E. Nabofa, Oluwadamilola O. Alashe, Oyetunde T. Oyeyemi, Alfred F. Attah, Ademola A. Oyagbemi, Temidayo O. Omobowale, Adeolu A. Adedapo & Akinola R. A. Alada. (2018) Cardioprotective Effects of Curcumin-Nisin Based Poly Lactic Acid Nanoparticle on Myocardial Infarction in Guinea Pigs. Scientific Reports 8:1.
Crossref
Ivan Kopljar, An De Bondt, Petra Vinken, Ard Teisman, Bruce Damiano, Nick Goeminne, Ilse Van den Wyngaert, David J Gallacher & Hua Rong Lu. (2017) Chronic drug-induced effects on contractile motion properties and cardiac biomarkers in human induced pluripotent stem cell-derived cardiomyocytes. British Journal of Pharmacology 174:21, pages 3766-3779.
Crossref
Samaa Alrushaid, Casey Sayre, Jaime Yáñez, M. Forrest, Sanjeewa Senadheera, Frank Burczynski, Raimar Löbenberg & Neal Davies. (2017) Pharmacokinetic and Toxicodynamic Characterization of a Novel Doxorubicin Derivative. Pharmaceutics 9:4, pages 35.
Crossref
Giuseppina Novo, Christian Cadeddu, Vincenzo Sucato, Pasquale Pagliaro, Silvio Romano, Carlo G. Tocchetti, Concetta Zito, Luca Longobardo, Savina Nodari & Maria Penco. (2016) Role of biomarkers in monitoring antiblastic cardiotoxicity. Journal of Cardiovascular Medicine 17, pages e27-e34.
Crossref
P. S. Terse, P. S. Joshi, N. R. Bordelon, A. M. Brys, K. M. Patton, T. P. Arndt & T. P. Sutula. (2016) 2-Deoxy- d -Glucose (2-DG)–Induced Cardiac Toxicity in Rat . International Journal of Toxicology 35:3, pages 284-293.
Crossref
Misbat Chaudry, Jose Banchs & Mariana Chavez-MacGregor. (2016) Anthracycline or trastuzumab-related cardiotoxicity: do we have a predictive biomarker?. Biomarkers in Medicine 10:3, pages 315-328.
Crossref
Dhssraj Singh, Akanksha Thakur & W. H. Wilson Tang. (2015) Utilizing Cardiac Biomarkers to Detect and Prevent Chemotherapy-Induced Cardiomyopathy. Current Heart Failure Reports 12:3, pages 255-262.
Crossref
Gül Erdemli, Haisong Ju & Sarita Pereira. 2015. Antitargets and Drug Safety. Antitargets and Drug Safety 279 294 .
Martin L. Katz, Joan R. Coates, Christine M. Sibigtroth, Jacob D. Taylor, Melissa Carpentier, Whitney M. Young, Fred A. Wininger, Derek Kennedy, Brian R. Vuillemenot & Charles A. O'Neill. (2014) Enzyme replacement therapy attenuates disease progression in a canine model of late‐infantile neuronal ceroid lipofuscinosis ( CLN 2 disease) . Journal of Neuroscience Research 92:11, pages 1591-1598.
Crossref
Sibo Tian, Kim M. Hirshfield, Salma K. Jabbour, Deborah Toppmeyer, Bruce G. Haffty, Atif J. Khan & Sharad Goyal. (2014) Serum Biomarkers for the Detection of Cardiac Toxicity after Chemotherapy and Radiation Therapy in Breast Cancer Patients. Frontiers in Oncology 4.
Crossref
Laura Cove-Smith, Neil Woodhouse, Adam Hargreaves, Jason Kirk, Susan Smith, Sally A. Price, Melanie Galvin, Catherine J. Betts, Simon Brocklehurst, Alison Backen, John Radford, Kim Linton, Ruth A. Roberts, Matthias Schmitt, Caroline Dive, Jonathan D. Tugwood, Paul D. Hockings & Howard R. Mellor. (2014) An Integrated Characterization of Serological, Pathological, and Functional Events in Doxorubicin-Induced Cardiotoxicity. Toxicological Sciences 140:1, pages 3-15.
Crossref
Bassim Mohammad, Nada Aharis, Maitham Yousif, Zainab Alkefae & Najah Hadi. (2013) Effects of caffeic acid on doxorubicin induced cardiotoxicity in rats. American Journal of BioMedicine 2:1, pages 23-27.
Crossref
Eduard Jirkovský, Olga Lenčová-Popelová, Miloš Hroch, Michaela Adamcová, Yvona Mazurová, Jaroslava Vávrová, Stanislav Mičuda, Tomáš Šimůnek, Vladimír Geršl & Martin Štěrba. (2013) Early and delayed cardioprotective intervention with dexrazoxane each show different potential for prevention of chronic anthracycline cardiotoxicity in rabbits. Toxicology 311:3, pages 191-204.
Crossref
G. Saravanan, P. Ponmurugan, M. Sathiyavathi, S. Vadivukkarasi & S. Sengottuvelu. (2013) Cardioprotective activity of Amaranthus viridis Linn: Effect on serum marker enzymes, cardiac troponin and antioxidant system in experimental myocardial infarcted rats. International Journal of Cardiology 165:3, pages 494-498.
Crossref
Alessandro Colombo, Carlo Cipolla, Marta Beggiato & Daniela Cardinale. (2013) Cardiac Toxicity of Anticancer Agents. Current Cardiology Reports 15:5.
Crossref
Alessandro ColomboDaniela Cardinale. (2013) Using cardiac biomarkers and treating cardiotoxicity in cancer. Future Cardiology 9:1, pages 105-118.
Crossref
Martina Vasatova, Radek Pudil, Jan M. Horacek & Tomas Buchler. 2013. 33 65 .
S Romano, S Fratini, E Ricevuto, V Procaccini, G Stifano, M Mancini, M Di Mauro, C Ficorella & M Penco. (2011) Serial measurements of NT-proBNP are predictive of not-high-dose anthracycline cardiotoxicity in breast cancer patients. British Journal of Cancer 105:11, pages 1663-1668.
Crossref
Jan M. Horáček. (2011) BIOMARKERS OF CARDIAC INJURY IN DETECTION OF CARDIOTOXICITY INDUCED BY CHEMOTHERAPEUTIC AGENTS. Military Medical Science Letters 80:3, pages 103-117.
Crossref
D. Cardinale & C.M. Cipolla. (2011) Assessment of cardiotoxicity with cardiac biomarkers in cancer patientsNachweis kardiotoxischer Nebenwirkungen mit kardiospezifischen Biomarkern bei Krebspatienten. Herz 36:4, pages 325-332.
Crossref
I. Mikaelian, A. Buness, G. Hirkaler, R. Fernandes, D. Coluccio, W. Geng, T. Visalli, M.O. Bachynsky, W. Berkofsky-Fessler, C. Kanwal, H. Hilton, R. Nicklaus, J.-C. Hoflack, M. Dunn, M. Sanders, M. Giron, B.W. Boyle, T. Singer & L. Suter Dick. (2011) Serum cardiac troponin I concentrations transiently increase in rats given rosiglitazone. Toxicology Letters 201:2, pages 110-115.
Crossref
Henrik Andersson, Bertil Kågedal & Carl-Fredrik Mandenius. (2010) Monitoring of troponin release from cardiomyocytes during exposure to toxic substances using surface plasmon resonance biosensing. Analytical and Bioanalytical Chemistry 398:3, pages 1395-1402.
Crossref
Peter Clements, Sally Brady, Malcolm York, Brian Berridge, Igor Mikaelian, Rosemary Nicklaus, Mitul Gandhi, Ian Roman, Clare Stamp, Dai Davies, Paul McGill, Thomas Williams, Syril Pettit, Dana Walker & John Turton. (2010) Time Course Characterization of Serum Cardiac Troponins, Heart Fatty Acid–binding Protein, and Morphologic Findings With Isoproterenol-induced Myocardial Injury in the Rat. Toxicologic Pathology 38:5, pages 703-714.
Crossref
Richard D. Beger, Jinchun Sun & Laura K. Schnackenberg. (2010) Metabolomics approaches for discovering biomarkers of drug-induced hepatotoxicity and nephrotoxicity. Toxicology and Applied Pharmacology 243:2, pages 154-166.
Crossref
Sylvie Gosselin, Lila Ramaiah & Lesley Earl. 2009. General and Applied Toxicology. General and Applied Toxicology.
Igor Mikaelian, Denise Coluccio, Gerard M. Hirkaler, John C. Downing, Erik Rasmussen, John Todd, Joel Estis, Quynh Anh Lu & Rosemary Nicklaus. (2009) Assessment of the Toxicity of Hydralazine in the Rat Using an Ultrasensitive Flow-based Cardiac Troponin I Immunoassay. Toxicologic Pathology 37:7, pages 878-881.
Crossref
Přemysl MladěnkaRadomír Hrdina, Zuzana Bobrovová, Vladimír Semecký, Jaroslava Vávrová, Magdaléna Holečková, Vladimir Palicka, Yvona Mazurová & Petr Nachtigal. (2009) Cardiac biomarkers in a model of acute catecholamine cardiotoxicity. Human & Experimental Toxicology 28:10, pages 631-640.
Crossref
Steven K. Engle, William H. Jordan, Michael L. Pritt, Alan Y. Chiang, Myrtle A. Davis, John L. Zimmermann, Daniel G. Rudmann, Kathleen M. Heinz-Taheny, Armando R. Irizarry, Yumi Yamamoto, David Mendel, A. Eric Schultze, Paul D. Cornwell & David E. Watson. (2009) Qualification of Cardiac Troponin I Concentration in Mouse Serum Using Isoproterenol and Implementation in Pharmacology Studies to Accelerate Drug Development. Toxicologic Pathology 37:5, pages 617-628.
Crossref
Hao Yu, Yan Meng, Li-Shun Wang, Xian Jin, Li-Fang Gao, Lei Zhou, Kun Ji, Yang Li, Li-Juan Zhao, Guo-Qiang Chen, Xue-Jian Zhao & Baoxue Yang. (2009) Differential protein expression in heart in UT-B null mice with cardiac conduction defects. PROTEOMICS 9:3, pages 504-511.
Crossref
Daniela Cardinale, Alessandro Colombo & Carlo Maria Cipolla. (2008) Prevention and treatment of cardiomyopathy and heart failure in patients receiving Cancer Chemotherapy. Current Treatment Options in Cardiovascular Medicine 10:6, pages 486-495.
Crossref
Peter James O’Brien. (2008) Cardiac troponin is the most effective translational safety biomarker for myocardial injury in cardiotoxicity. Toxicology 245:3, pages 206-218.
Crossref
Jan M. Horacek, Milos Tichy, Radek Pudil, Ladislav Jebavy, Pavel Zak, Martina Ulrychova, Jaroslava Vavrova, Jaroslav Maly & Vladimir Palicka. (2008) New biomarkers of myocardial injury and assessment of cardiac toxicity during preparative regimen and hematopoietic cell transplantation in acute leukemia. Clinical Chemistry and Laboratory Medicine 46:1.
Crossref
Michaela Adamcová, Tomáš Šimůnek, Helena Kaiserová, Olga Popelová, Martin Štěrba, Anna Potáčová, Jaroslava Vávrová, Jana Maláková & Vladimír Geršl. (2007) In vitro and in vivo examination of cardiac troponins as biochemical markers of drug-induced cardiotoxicity. Toxicology 237:1-3, pages 218-228.
Crossref
Malcolm York, Cheryl Scudamore, Sally Brady, Christabelle Chen, Sharon Wilson, Mark Curtis, Gareth Evans, William Griffiths, Matthew Whayman, Thomas Williams & John Turton. (2016) Characterization of Troponin Responses in Isoproterenol-Induced Cardiac Injury in the Hanover Wistar Rat. Toxicologic Pathology 35:4, pages 606-617.
Crossref
Martin Štěrba, Olga Popelová, Tomáš Šimůnek, Yvona Mazurová, Anna Potáčová, Michaela Adamcová, Helena Kaiserová, Přemysl Poňka & Vladimír Geršl. (2006) Cardioprotective Effects of a Novel Iron Chelator, Pyridoxal 2-Chlorobenzoyl Hydrazone, in the Rabbit Model of Daunorubicin-Induced Cardiotoxicity. Journal of Pharmacology and Experimental Therapeutics 319:3, pages 1336-1347.
Crossref
Smadar Yitzhaki, Asher Shainberg, Yelena Cheporko, Bernardo A. Vidne, Alex Sagie, Kenneth A. Jacobson & Edith Hochhauser. (2006) Uridine-5′-triphosphate (UTP) reduces infarct size and improves rat heart function after myocardial infarct. Biochemical Pharmacology 72:8, pages 949-955.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.